Description: Forever chemicals (also known as PFAS chemicals) have become a media focus over the past 12 months around the globe. This attention has arisen due to PFAS chemicals being detected in many areas of our environment and in manufactured goods, including water, food products, cookware, and potentially pharmaceuticals. Of major concern are the health impacts of these chemicals on humans and other living organisms. New regulations being considered by the European Chemicals Agency may disrupt the use of PFAS chemicals in pharmaceutical manufacturing systems. Participants will gain an understanding of PFAS chemicals with regard to their potential health impacts, current uses in pharmaceutical manufacturing, and a replacement filter membrane recently developed by Sartorius.
Forever chemicals – Imagine Not being Able to use PVDF tomorrow
Organisation:
Michael Schafferius
Michael Schafferius is currently the Product Specialist for Filtration Asia (excluding China) at Sartorius. He has been with Sartorius for 13 years and brings over 20 years of experience in the pharmaceutical and biopharmaceutical sectors. Michael’s expertise encompasses Filtration, Single-Use Technologies, Quality Assurance, Validation, and Sterile Manufacturing, gained through roles in both local and international companies. He is a recognized subject matter expert in Pre-Use Post-Sterilization Integrity Testing of filters and frequently presents on this topic at regional conferences. Michael concluded his term as President of the Parenteral Drug Association (PDA) Australia Chapter in 2024 and continues to contribute as an active core committee member.
